| Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial F Bril, DM Biernacki, S Kalavalapalli, R Lomonaco, SK Subbarayan, J Lai, ... Diabetes care 42 (8), 1481-1488, 2019 | 306 | 2019 |
| Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening R Lomonaco, E Godinez Leiva, F Bril, S Shrestha, L Mansour, J Budd, ... Diabetes Care 44 (2), 399-406, 2021 | 301 | 2021 |
| Response to pioglitazone in patients with nonalcoholic steatohepatitis with vs without type 2 diabetes F Bril, S Kalavalapalli, VC Clark, R Lomonaco, C Soldevila-Pico, IC Liu, ... Clinical Gastroenterology and Hepatology 16 (4), 558-566. e2, 2018 | 202 | 2018 |
| Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity RE Patterson, S Kalavalapalli, CM Williams, M Nautiyal, JT Mathew, ... American Journal of Physiology-Endocrinology and Metabolism 310 (7), E484-E494, 2016 | 185 | 2016 |
| Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes K Cusi, F Bril, D Barb, D Polidori, S Sha, A Ghosh, K Farrell, NE Sunny, ... Diabetes, Obesity and Metabolism 21 (4), 812-821, 2019 | 184 | 2019 |
| Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease NE Sunny, S Kalavalapalli, F Bril, TJ Garrett, M Nautiyal, JT Mathew, ... American Journal of Physiology-Endocrinology and Metabolism 309 (4), E311-E319, 2015 | 124 | 2015 |
| Plasma fibroblast growth factor 21 is associated with severity of nonalcoholic steatohepatitis in patients with obesity and type 2 diabetes D Barb, F Bril, S Kalavalapalli, K Cusi The Journal of Clinical Endocrinology & Metabolism 104 (8), 3327-3336, 2019 | 93 | 2019 |
| Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis S Kalavalapalli, F Bril, JP Koelmel, K Abdo, J Guingab, P Andrews, WY Li, ... American Journal of Physiology-Endocrinology and Metabolism 315 (2), E163-E173, 2018 | 66 | 2018 |
| Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance J Cho, Y Zhang, SY Park, AM Joseph, C Han, HJ Park, S Kalavalapalli, ... Nature communications 8 (1), 14477, 2017 | 64 | 2017 |
| Use of a metabolomic approach to non‐invasively diagnose non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus F Bril, L Millán, S Kalavalapalli, MJ McPhaul, MP Caulfield, ... Diabetes, Obesity and Metabolism 20 (7), 1702-1709, 2018 | 55 | 2018 |
| Use of plasma fragments of propeptides of type III, V, and VI procollagen for the detection of liver fibrosis in type 2 diabetes F Bril, DJ Leeming, MA Karsdal, S Kalavalapalli, D Barb, J Lai, M Rabe, ... Diabetes Care 42 (7), 1348-1351, 2019 | 52 | 2019 |
| Improved experimental data processing for UHPLC–HRMS/MS lipidomics applied to nonalcoholic fatty liver disease RE Patterson, AS Kirpich, JP Koelmel, S Kalavalapalli, AM Morse, K Cusi, ... Metabolomics 13, 1-11, 2017 | 51 | 2017 |
| Clinical and histologic characterization of nonalcoholic steatohepatitis in African American patients F Bril, P Portillo-Sanchez, IC Liu, S Kalavalapalli, K Dayton, K Cusi Diabetes care 41 (1), 187-192, 2018 | 45 | 2018 |
| Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis S Kalavalapalli, F Bril, J Guingab, A Vergara, TJ Garrett, NE Sunny, ... Journal of Endocrinology 241 (3), 293-305, 2019 | 42 | 2019 |
| Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes F Bril, S Kadiyala, P Portillo Sanchez, NE Sunny, D Biernacki, M Maximos, ... Journal of investigative medicine 64 (1), 63-68, 2016 | 42 | 2016 |
| Genomic landscape of primary mediastinal B-cell lymphoma cell lines H Dai, S Ehrentraut, S Nagel, S Eberth, C Pommerenke, WG Dirks, ... PLoS One 10 (11), e0139663, 2015 | 31 | 2015 |
| Adipose tissue insulin resistance predicts the severity of liver fibrosis in patients with type 2 diabetes and NAFLD S Kalavalapalli, EG Leiva, R Lomonaco, X Chi, S Shrestha, R Dillard, ... The Journal of Clinical Endocrinology & Metabolism 108 (5), 1192-1201, 2023 | 27 | 2023 |
| Concentration‐dependent response to pioglitazone in nonalcoholic steatohepatitis M Kawaguchi‐Suzuki, F Bril, S Kalavalapalli, K Cusi, RF Frye Alimentary pharmacology & therapeutics 46 (1), 56-61, 2017 | 27 | 2017 |
| Intact fasting insulin identifies nonalcoholic fatty liver disease in patients without diabetes F Bril, MJ McPhaul, S Kalavalapalli, R Lomonaco, D Barb, ME Gray, ... The Journal of Clinical Endocrinology & Metabolism 106 (11), e4360-e4371, 2021 | 16 | 2021 |
| Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes KA Dayton, F Bril, D Barb, J Lai, S Kalavalapalli, K Cusi PLoS One 16 (6), e0251449, 2021 | 16 | 2021 |
